NAD+ Precursors (NMN/NR) Side Effects: Safety Signals and Warnings
NAD+ Precursors (NMN/NR) safety concerns are compound-specific. The main listed side effects are Mild nausea, Flushing, and Headache. The main warning signals are Long-term safety data beyond 12 months is limited, Theoretical concern about promoting growth of existing cancers via NAD+-dependent pathways, and Quality and purity of supplements vary significantly between manufacturers.
Direct Answer
NAD+ precursors (NMN/NR) have Phase 2 human data demonstrating reliable NAD+ elevation in blood, with emerging evidence for metabolic, cardiovascular, and muscle function benefits. The evidence is not yet at Phase 3 scale for any single indication, but the mechanistic foundation and human safety data are solid across multiple independent groups. For longevity-adjacent interventions with actual human data, NAD+ precursors are the most evidence-supported option in this category.
- Evidence grade
- Level B
- Research status
- Phase 2
- Category
- Anti-Aging & Longevity
- Best for
- NAD+ restoration, metabolic aging research, cardiovascular risk factor modulation, muscle function in aging
Reported Side Effects
- Mild nausea
- Flushing
- Headache
- Gastrointestinal discomfort
- Insomnia at high doses
Warnings
- Long-term safety data beyond 12 months is limited
- Theoretical concern about promoting growth of existing cancers via NAD+-dependent pathways
- Quality and purity of supplements vary significantly between manufacturers
Known or Plausible Interactions
- Resveratrol (potential synergy with sirtuin activation)
- Chemotherapy drugs (NAD+ may alter drug metabolism)
- Metformin (overlapping AMPK pathway effects)
Regulatory Context
Available as dietary supplement in most countries; NMN banned as supplement in some jurisdictions pending further review.
Evidence Snapshot
| Evidence grade | Level B |
|---|---|
| Research status | Phase 2 |
| Best supported outcomes | Cellular NAD+ Restoration (Level B), Mitochondrial Function (Level B), and Insulin Sensitivity (Level C) |
| Primary citation count | 3 |
| Last reviewed | 2026-04-04 |
Related Guides
How to Cite This Page
ExaminePeptides. "NAD+ Precursors (NMN/NR) Side Effects: Safety Signals and Warnings." Last reviewed 2026-04-04. https://examinepeptides.com/answers/nad-plus-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.